Avadel pharmaceuticals plc (AVDL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Total revenues

59,215

103,269

173,245

150,246

-

-

-

-

-

-

-

Product sales

-

-

-

-

172,288

12,193

1,153

560

13,395

8,180

11,871

License revenue

-

-

-

-

721

2,782

3,026

6,724

10,566

19,704

20,815

Other revenues

-

-

-

-

-

-

-

250

8,639

9,210

9,432

Total revenues

-

-

-

-

173,009

14,975

4,179

7,534

32,600

37,094

42,118

Operating expenses:
Cost of products

12,125

17,516

16,301

13,248

11,410

3,383

562

400

6,284

6,914

-10,118

Research and development expenses

32,917

39,329

33,418

34,611

25,608

17,298

15,966

14,558

25,089

28,687

-30,416

Selling, general and administrative expenses

30,183

100,359

58,860

44,179

21,712

15,698

13,216

14,153

10,810

11,333

-13,337

Fair value remeasurement of acquisition liabilities, with related parties

-

-

-

-

-

-

-

-18,834

-

-

-

Remeasurement of acquisition liabilities

-

-

-

-

-

-

-

-

0

0

-

Impairment of assets

-

-

-

-

-

-

-

7,170

0

0

-

Intangible asset amortization

816

6,619

3,659

13,888

12,564

11,749

0

0

-

-

-

Business Combination, Acquisition Related Costs

845

-22,731

-31,040

49,285

30,957

57,491

28,135

-

-

-

-

Impairment of intangible asset

0

66,087

0

0

-

-

-

-

-

-

-

Restructuring costs

6,441

1,016

2,542

0

0

-

-

-

-

-

-

Loss on early repayment of related party acquisition-related note

-

-

-

-

-

3,013

0

0

-

-

-

Total operating expenses

83,327

208,195

83,740

155,211

102,251

108,632

57,879

17,447

42,183

46,934

-53,871

Operating loss

-24,112

-104,926

89,505

-4,965

70,758

-93,657

-53,700

-9,913

-9,583

-9,840

-11,753

Investment and other income, net

1,069

452

2,136

2,758

1,236

927

254

-

-

-

-

Interest expense

-

-

-

-

-

-

-

118

73

24

100

Interest income net

-

-

-

-

-

-

-

-

-

-

525

Interest expense

12,483

10,622

1,052

963

0

5,747

2,602

0

0

-

-

Loss on deconsolidation of subsidiary

-2,678

0

0

-

-

-

-

-

-

-

-

Other expense - changes in fair value of contingent consideration payable

-378

1,899

2,071

-6,548

-4,883

-

573

-

-

-

-

Other expense - changes in fair value of related party payable

-

-

-

-

-

3,525

1,990

-

-

-

-

Interest income

-

-

-

-

-

-

-

640

667

464

-

Foreign exchange (loss) gain

-

-

-

-

10,594

11,871

-288

-180

273

109

-83

Other Income

-

-

-

-

-

-

-

102

134

525

-28

Loss before income taxes

-38,582

-113,197

92,660

-9,718

77,705

-90,131

-57,753

-9,469

-8,582

-8,766

-11,439

Income tax benefit

-5,356

-17,893

24,389

31,558

35,907

-644

-11,244

-4,729

192

209

-

Net income (loss) from continuing operations

-

-

-

-

-

-89,487

-46,509

-4,740

-

-

-

Net income from discontinued operations

-

-

-

-

-

4,018

3,584

1,512

-

-

-

Net Income (Loss) Attributable to Parent

-33,226

-95,304

68,271

-41,276

41,798

-85,469

-42,925

-3,228

-8,774

-8,975

-11,439

Earnings Per Share [Abstract]
Continuing operations (in usd per share)

-

-

-

-

-

-2.47

-1.83

-0.19

-

-

-

Discontinued operations (in usd per share)

-

-

-

-

-

0.11

0.14

0.06

-

-

-

Net income (loss) per share - basic (in dollars per share)

-0.89

-2.55

1.69

-1.00

1.03

-2.36

-1.69

-0.13

-0.36

-0.37

-0.47

Continuing operations (in usd per share)

-

-

-

-

-

-2.47

-1.83

-0.19

-

-

-

Discontinued operations (in usd per share)

-

-

-

-

-

0.11

0.14

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

0.06

-

-

-

Net income (loss) per share - diluted (in dollars per share)

-0.89

-2.55

1.63

-1.00

0.96

-2.36

-1.69

-0.13

-0.36

-0.37

-0.47

Weighted average number of shares outstanding
Weighted average number of shares outstanding - basic (in shares)

37,403

37,325

40,465

41,248

40,580

36,214

25,450

25,135

24,669

24,411

24,225

Weighted average number of shares outstanding - diluted (in shares)

37,403

37,325

41,765

41,248

43,619

36,214

25,450

25,135

24,669

24,411

24,225

Product sales
Total revenues

59,215

101,423

172,841

147,222

-

-

-

-

-

-

-

License revenue
Total revenues

0

1,846

404

3,024

-

-

-

-

-

-

-